Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769026 · ClinicalTrials.gov registry record
Prognostication Biomarkers in Pediatric Cardiac Arrest
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 164
- Enrollment target
NCT02769026: Completed study, sponsored by University of Pittsburgh.
NCT02769026 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769026 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
This multicenter study will validate a panel of serum, imaging, and clinical biomarkers to classify patient outcome early after out-of-hospital pediatric cardiac arrest. Results are expected to have a positive and immediate impact in advancing clinical care and outcomes for these children. This work will provide clinicians, families, and researchers with superior tools to assess the severity of brain injury early after resuscitation in order to know who is at risk of brain injury and may benefit from neuroprotective interventions, to monitor response to these interventions, to plan rehabilitation strategy, and to optimize the design of research studies that test novel interventions to improve neurological outcome after cardiac arrest.
Primary Outcome
Evaluate serum, imaging, and clinical biomarkers individually and in combined models to classify favorable outcome at 1 year post-CA (Favorable outcome at 1 year post-CA is a VABS score \> 70).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2021-03-01 |
What the finished NCT02769026 record still lists
NCT02769026 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02769026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769026 about?
NCT02769026 is a clinical study titled "Prognostication Biomarkers in Pediatric Cardiac Arrest". This multicenter study will validate a panel of serum, imaging, and clinical biomarkers to classify patient outcome early after out-of-hospital pediatric cardiac arrest. Results are expected to have a positive and immediate impact in advancing clinical care and outcomes for these children. This work...
What is the current status of trial NCT02769026?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2017-06-01. Estimated completion is 2021-03-01.
Who is sponsoring clinical trial NCT02769026?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI